AgenT logo

AgenT

Detect Alzheimer's earlier, when it could be prevented

39 employees · est. 2018 · Paris, France

VS
Nuravax logo

Nuravax

#vaccine #Alzheimer's #Parkinson's

3 employees · Los Angeles, United States

AgenT is the larger of the two.

Side-by-Side Comparison

AgenT Nuravax
Founded
2018 Not tracked yet
Headquarters
Paris, France Los Angeles, United States
Employees
39 larger 3
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Life Sciences
Funding Stage
Unknown Not tracked yet
Total Funding
$2.80M Not tracked yet
Funding Rounds
5 Not tracked yet
Services
Blood test development for early Alzheimer's detection, Machine learning modeling for disease analysis, Multiomics biomarker research Not tracked yet
Target Customers
Healthcare providers, Neurologists, Clinical researchers, Biotech partnerships, Patients at risk of Alzheimer's Not tracked yet
Taxonomy
Life Sciences, Alzheimer's Disease, Multi-omics Assays, Blood Biomarkers, Early Diagnosis, Precision Therapies, Healthcare Innovation Vaccine Development, Neurodegenerative Disorders, Alzheimer's Prevention, Parkinson's Prevention, Universal Vaccine Platform, Blood-brain Barrier Penetration, Pathological Plaques Prevention, Fibrils Prevention, Oligomers Prevention, Cognitive Impairment Prevention, Nuravax, California-based
Website
agent-biotech.com nuravax.com
AgenT logo

About AgenT

AgenT is a pioneering life sciences startup established in 2018, headquartered in France. The company's mission, encapsulated by its slogan, "Detect Alzheimer's earlier, when it could be prevented," focuses on combating Alzheimer's disease during its silent phase. By leveraging cutting-edge multi-om...

Nuravax logo

About Nuravax

Nuravax is a biotechnology startup based in the United States with a mission to develop effective and affordable preventive vaccines for Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. The company's universal vaccine platform for Alzheimer’s aims to induce antibody t...

We will tell you when either one moves

BounceWatch watches AgenT and Nuravax for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AgenT and Nuravax — by email.

Frequently Asked Questions

AgenT — Detect Alzheimer's earlier, when it could be prevented . Nuravax — #vaccine #Alzheimer's #Parkinson's. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AgenT has raised $2.80M while Nuravax has raised undisclosed funding.
AgenT and Nuravax operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AgenT with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AgenT on 11 Jun 2025, and Nuravax on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy